Active	Status	Sponsor type	Region	Phase	Filter
5 Active 7 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jemec, Gregor BE
OSIRIS, NCT04982432 / 2021-000049-42: Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa	Not yet recruiting	2	24	NA	Orismilast, UNI5001	Gregor Jemec, UNION therapeutics	Hidradenitis Suppurativa	12/22	12/22
RECAST DLE, NCT05591222 / 2022-000831-21: Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus	Active, not recruiting	2	72	Europe, Canada, US, RoW	Placebo, Daxdilimab, HZN-7734	Amgen, Horizon Therapeutics Ireland DAC	Discoid Lupus Erythematosus	08/25	08/25
NCT04508374: Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa	Recruiting	N/A	20	Europe	1470 nm intra-lesional diode laser treatment of right HS tunnel, 1470 nm intra-lesional diode laser treatment of left HS tunnel	Zealand University Hospital	Hidradenitis Suppurativa	09/22	09/25
BCC-HIFU2101, NCT05133427: HIFU for Treatment of Non-nodular and Recurrent BCC	Recruiting	N/A	40	Europe	TOOsonix system ONE-M	Joergen Serup, Zealand University Hospital	Carcinoma, Basal Cell	12/24	12/24
NCT05284877: The Organ Transplant Recipient HPV and Skin Cancer Study	Recruiting	N/A	1500	Europe	No intervention	Merete Haedersdal, Danish Cancer Society, Zealand University Hospital, Vejle Hospital, Herlev and Gentofte Hospital, Rigshospitalet, Denmark	Solid Organ Transplant Recipient, Skin Cancer, Skin Dysplasia, HPV Infection, Cervical Intraepithelial Neoplasia, Cervical Cancer, HPV-Related Malignancy	03/28	03/43

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jemec, Gregor BE
OSIRIS, NCT04982432 / 2021-000049-42: Orismilast for the Treatment of Mild to Severe Hidradenitis Suppurativa	Not yet recruiting	2	24	NA	Orismilast, UNI5001	Gregor Jemec, UNION therapeutics	Hidradenitis Suppurativa	12/22	12/22
RECAST DLE, NCT05591222 / 2022-000831-21: Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus	Active, not recruiting	2	72	Europe, Canada, US, RoW	Placebo, Daxdilimab, HZN-7734	Amgen, Horizon Therapeutics Ireland DAC	Discoid Lupus Erythematosus	08/25	08/25
NCT04508374: Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa	Recruiting	N/A	20	Europe	1470 nm intra-lesional diode laser treatment of right HS tunnel, 1470 nm intra-lesional diode laser treatment of left HS tunnel	Zealand University Hospital	Hidradenitis Suppurativa	09/22	09/25
BCC-HIFU2101, NCT05133427: HIFU for Treatment of Non-nodular and Recurrent BCC	Recruiting	N/A	40	Europe	TOOsonix system ONE-M	Joergen Serup, Zealand University Hospital	Carcinoma, Basal Cell	12/24	12/24
NCT05284877: The Organ Transplant Recipient HPV and Skin Cancer Study	Recruiting	N/A	1500	Europe	No intervention	Merete Haedersdal, Danish Cancer Society, Zealand University Hospital, Vejle Hospital, Herlev and Gentofte Hospital, Rigshospitalet, Denmark	Solid Organ Transplant Recipient, Skin Cancer, Skin Dysplasia, HPV Infection, Cervical Intraepithelial Neoplasia, Cervical Cancer, HPV-Related Malignancy	03/28	03/43